Our project was selected for the AMED “Drug Discovery Venture Ecosystem Enhancement Project”.
The Japan Agency for Medical Research and Development (AMED) has selected us as an implementing organisation for the 4th ‘Drug Discovery Venture Ecosystem Enhancement Project (Drug Discovery Venture Open Call)’ in 2024.
We will take this opportunity to further accelerate the development of tooth regeneration therapies.
Subsidised project subject: Development of a novel antibody medicine to regenerate missing teeth in patients with congenital edentulism.